TransCode Therapeutics, Inc. (RNAZ) SEC filings
RNAZ SEC filings moved a median of -1.63% by the close. RNAZ SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the RNAZ overview →
122 measured RNAZ SEC filing events.
Where these RNAZ SEC filings landedvs 122 measured RNAZ SEC filing reactions
| Middle 50% of RNAZ SEC filing reactions | -5.93% to +2.84% |
|---|---|
| Median reaction (to close) | -1.63% |
| Measured reactions | 122 |
Point-in-time · zero look-ahead
Half of the 122 RNAZ SEC filing events with a measured close landed between -5.93% and +2.84%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Transcode Therapeutics, For: Oct 01 | SEC filing · Form 8-K | +0.00% | -0.63% | |
| Form 8-K Transcode Therapeutics, For: Sep 28 | SEC filing · Form 8-K | — | +3.01% | |
| Form 8-K Transcode Therapeutics, For: Sep 09 | SEC filing · Form 8-K | +0.00% | +0.00% | |
| Form 10-Q Transcode Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -7.49% | -5.95% | |
| Form 8-K Transcode Therapeutics, For: Aug 03 | SEC filing · Form 8-K | +7.76% | +1.60% | |
| Form 8-K Transcode Therapeutics, For: Jul 20 | SEC filing · Form 8-K | — | -2.44% | |
| Form 8-K Transcode Therapeutics, For: Jul 16 | SEC filing · Form 8-K | +0.00% | +0.58% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | +0.00% | +0.58% | |
| Form 8-K Transcode Therapeutics, For: Jul 02 | SEC filing · Form 8-K | -1.74% | -12.70% | |
| Form 8-K Transcode Therapeutics, For: Jun 18 | SEC filing · Form 8-K | — | -9.44% | |
| Form 8-K Transcode Therapeutics, For: Jun 03 | SEC filing · Form 8-K | -0.82% | +18.59% | |
| Form ARS Transcode Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.82% | +18.59% | |
| Form DEF 14A Transcode Therapeutics, For: Jul 02 | SEC filing · Form DEF | -0.82% | +18.59% | |
| Form 8-K Transcode Therapeutics, For: May 29 | SEC filing · Form 8-K | +4.87% | +5.95% | |
| Form 8-K/A Transcode Therapeutics, For: May 19 | SEC filing · Form 8-K | -3.68% | -0.74% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -3.68% | -0.74% | |
| Form 8-K Transcode Therapeutics, For: May 19 | SEC filing · Form 8-K | -3.68% | -0.74% | |
| Form EFFECT Transcode Therapeutics, | SEC filing · Form EFFECT | — | -1.45% | |
| Form 10-Q Transcode Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | -6.51% | |
| Form PRE 14A Transcode Therapeutics, For: May 08 | SEC filing · Form PRE | -1.54% | -1.69% | |
| Form S-1 Transcode Therapeutics, | SEC filing · Form S-1 | — | -6.79% | |
| Form 10-K/A Transcode Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | -4.69% | |
| Form S-3 Transcode Therapeutics, | SEC filing · Form S-3 | — | -4.69% | |
| Form 10-K Transcode Therapeutics, For: Dec 31 | SEC filing · Form 10-K | — | -2.03% | |
| Form 8-K Transcode Therapeutics, For: Apr 06 | SEC filing · Form 8-K | — | -3.97% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | — | -3.97% | |
| Form NT 10-K Transcode Therapeutics, For: Dec 31 | SEC filing · Form NT | — | +1.40% | |
| Form 8-K Transcode Therapeutics, For: Mar 02 | SEC filing · Form 8-K | — | -1.21% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | — | -1.21% | |
| Form 8-K Transcode Therapeutics, For: Feb 23 | SEC filing · Form 8-K | -1.91% | -0.21% | |
| Form 8-K Transcode Therapeutics, For: Feb 05 | SEC filing · Form 8-K | -5.10% | -15.29% | |
| Form 8-K Transcode Therapeutics, For: Jan 06 | SEC filing · Form 8-K | +4.40% | +4.54% | |
| Form 8-K/A Transcode Therapeutics, For: Oct 08 | SEC filing · Form 8-K | +2.13% | -0.93% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | +2.13% | -0.93% | |
| Form EFFECT Transcode Therapeutics, | SEC filing · Form EFFECT | +0.00% | +2.17% | |
| Form 8-K Transcode Therapeutics, For: Dec 19 | SEC filing · Form 8-K | -2.57% | -7.15% | |
| Form S-3 Transcode Therapeutics, | SEC filing · Form S-3 | — | -5.03% | |
| Form 8-K Transcode Therapeutics, For: Dec 11 | SEC filing · Form 8-K | +0.00% | +6.33% | |
| Form 10-Q Transcode Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +4.56% | |
| Form 8-K Transcode Therapeutics, For: Oct 27 | SEC filing · Form 8-K | -1.31% | -4.44% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -1.31% | -4.44% | |
| Form 8-K/A Transcode Therapeutics, For: Oct 08 | SEC filing · Form 8-K | -0.63% | -2.06% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -0.63% | -2.06% | |
| Form 8-K Transcode Therapeutics, For: Oct 13 | SEC filing · Form 8-K | -1.47% | +4.62% | |
| Form 8-K Transcode Therapeutics, For: Oct 08 | SEC filing · Form 8-K | +3.92% | -3.27% | |
| Form 8-K/A Transcode Therapeutics, For: Oct 08 | SEC filing · Form 8-K | -0.83% | +11.21% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -0.07% | +3.42% | |
| TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company | Press release | -8.44% | -20.90% | |
| Form 8-K Transcode Therapeutics, For: Sep 30 | SEC filing · Form 8-K | +0.00% | +13.35% | |
| Form 8-K Transcode Therapeutics, For: Aug 29 | SEC filing · Form 8-K | +0.00% | -0.10% | |
| Form 10-Q Transcode Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -4.87% | -7.78% | |
| Form DEF 14A Transcode Therapeutics, For: Aug 29 | SEC filing · Form DEF | +0.00% | +5.22% | |
| Form 8-K Transcode Therapeutics, For: Jun 12 | SEC filing · Form 8-K | +0.00% | +8.15% | |
| Form 10-Q Transcode Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +0.31% | -7.27% | |
| Form 8-K Transcode Therapeutics, For: May 06 | SEC filing · Form 8-K | -7.04% | -1.44% | |
| Form 8-K Transcode Therapeutics, For: May 05 | SEC filing · Form 8-K | -1.52% | -11.47% | |
| Form 8-K Transcode Therapeutics, For: May 02 | SEC filing · Form 8-K | +1.33% | +1.86% | |
| Form 10-K/A Transcode Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +18.25% | +17.94% | |
| Form 8-K Transcode Therapeutics, For: Apr 21 | SEC filing · Form 8-K | -5.57% | -2.17% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -5.57% | -2.17% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -4.12% | -8.80% | |
| Form 10-K Transcode Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -4.12% | -8.80% | |
| Form DEF 14A Transcode Therapeutics, For: Apr 21 | SEC filing · Form DEF | -3.85% | +0.00% | |
| Form PRE 14A Transcode Therapeutics, For: Apr 02 | SEC filing · Form PRE | -2.44% | -1.97% | |
| Form NT 10-K Transcode Therapeutics, For: Dec 31 | SEC filing · Form NT | +1.29% | +14.16% | |
| Form 8-K Transcode Therapeutics, For: Mar 23 | SEC filing · Form 8-K | -2.82% | -2.37% | |
| Form 8-K Transcode Therapeutics, For: Feb 25 | SEC filing · Form 8-K | -12.50% | -16.25% | |
| Form 8-K Transcode Therapeutics, For: Feb 04 | SEC filing · Form 8-K | +5.47% | +35.87% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | +5.47% | +35.87% | |
| Form DEF 14A Transcode Therapeutics, For: Feb 04 | SEC filing · Form DEF | -1.43% | -12.47% | |
| Form 8-K Transcode Therapeutics, For: Dec 18 | SEC filing · Form 8-K | +1.06% | -4.79% | |
| Form PRE 14A Transcode Therapeutics, For: Feb 28 | SEC filing · Form PRE | -0.52% | -1.57% | |
| Form EFFECT Transcode Therapeutics, | SEC filing · Form EFFECT | -13.67% | -6.00% | |
| Form D Transcode Therapeutics, | SEC filing · Form D | — | +0.68% | |
| Form S-1 Transcode Therapeutics, | SEC filing · Form S-1 | +2.13% | -5.88% | |
| Form 8-K Transcode Therapeutics, For: Nov 26 | SEC filing · Form 8-K | +0.77% | -8.77% | |
| Form 8-K Transcode Therapeutics, For: Nov 26 | SEC filing · Form 8-K | -1.25% | -13.95% | |
| Form 8-K Transcode Therapeutics, For: Nov 22 | SEC filing · Form 8-K | -1.83% | -8.75% | |
| Form 10-Q Transcode Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.33% | +0.09% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | +0.00% | -4.74% | |
| Form 8-K Transcode Therapeutics, For: Nov 04 | SEC filing · Form 8-K | -1.37% | +0.54% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -1.37% | +0.54% | |
| Form DEF 14A Transcode Therapeutics, For: Nov 22 | SEC filing · Form DEF | -0.27% | -4.81% | |
| Form PRE 14A Transcode Therapeutics, For: Oct 15 | SEC filing · Form PRE | -10.21% | -9.02% | |
| Form 8-K Transcode Therapeutics, For: Sep 23 | SEC filing · Form 8-K | -3.65% | -9.37% | |
| Form 8-K Transcode Therapeutics, For: Aug 28 | SEC filing · Form 8-K | -1.43% | +5.46% | |
| Form 8-K Transcode Therapeutics, For: Aug 13 | SEC filing · Form 8-K | +1.53% | +3.09% | |
| Form 10-Q Transcode Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.21% | +8.27% | |
| Form 8-K Transcode Therapeutics, For: Jul 22 | SEC filing · Form 8-K | -0.94% | -3.26% | |
| Form 8-K/A Transcode Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +1.75% | +5.26% | |
| Form 8-K Transcode Therapeutics, For: Jun 13 | SEC filing · Form 8-K | +1.75% | +5.26% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | +1.10% | -5.15% | |
| Form 8-K Transcode Therapeutics, For: Jun 03 | SEC filing · Form 8-K | +1.10% | -5.15% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | +1.10% | -5.15% | |
| Form DEFR14A Transcode Therapeutics, | SEC filing · Form DEFR14A | +1.66% | +4.17% | |
| Form 10-Q Transcode Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.00% | +10.60% | |
| Form 8-K Transcode Therapeutics, For: May 15 | SEC filing · Form 8-K | +1.00% | +10.60% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | -6.36% | +32.74% | |
| Form 8-K Transcode Therapeutics, For: May 07 | SEC filing · Form 8-K | -6.14% | -45.95% | |
| Form PRE 14A Transcode Therapeutics, For: Jun 13 | SEC filing · Form PRE | -6.14% | -45.95% | |
| Form ARS Transcode Therapeutics, For: Dec 31 | SEC filing · Form ARS | -3.30% | +0.18% | |
| Form DEF 14A Transcode Therapeutics, For: Jun 13 | SEC filing · Form DEF | -3.30% | +0.18% | |
| Form 8-K Transcode Therapeutics, For: Apr 22 | SEC filing · Form 8-K | -5.77% | -1.30% | |
| Form 8-K Transcode Therapeutics, For: Apr 03 | SEC filing · Form 8-K | +0.00% | +2.34% | |
| Form 10-K Transcode Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +2.65% | +1.62% | |
| Form 8-K Transcode Therapeutics, For: Jan 26 | SEC filing · Form 8-K | +2.71% | -5.26% | |
| Form 8-K Transcode Therapeutics, For: Jan 18 | SEC filing · Form 8-K | -0.97% | -3.96% | |
| Form S-1/A Transcode Therapeutics, | SEC filing · Form S-1 | -14.15% | -50.23% | |
| Form S-1/A Transcode Therapeutics, | SEC filing · Form S-1 | -4.00% | -33.54% | |
| Form 8-K Transcode Therapeutics, For: Jan 10 | SEC filing · Form 8-K | -4.00% | -33.54% | |
| Form S-1 Transcode Therapeutics, | SEC filing · Form S-1 | +2.76% | +10.57% | |
| Form 8-K Transcode Therapeutics, For: Jan 08 | SEC filing · Form 8-K | -1.11% | -5.96% | |
| Form DEFA14A Transcode Therapeutics, | SEC filing · Form DEFA14A | — | -2.60% | |
| Form DEF 14A Transcode Therapeutics, For: Jan 08 | SEC filing · Form DEF | +0.19% | -4.56% | |
| Form 8-K Transcode Therapeutics, For: Dec 08 | SEC filing · Form 8-K | -3.99% | -14.02% | |
| Form PRE 14A Transcode Therapeutics, For: Dec 07 | SEC filing · Form PRE | -3.99% | -14.02% | |
| Form 8-K Transcode Therapeutics, For: Nov 30 | SEC filing · Form 8-K | +1.81% | +4.87% | |
| Form 10-Q Transcode Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.03% | -8.18% | |
| Form 8-K Transcode Therapeutics, For: Nov 14 | SEC filing · Form 8-K | +0.03% | -8.18% | |
| Form 8-K Transcode Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +2.61% | -4.46% | |
| Form 8-K Transcode Therapeutics, For: Oct 26 | SEC filing · Form 8-K | -0.81% | +12.47% | |
| Form 8-K Transcode Therapeutics, For: Oct 24 | SEC filing · Form 8-K | -6.16% | +17.78% |
Keep exploring
More RNAZ: earnings → · analyst actions → · RNAZ overview →